2023 - Research.com Medicine in Switzerland Leader Award
Bernard Thorens mainly focuses on Internal medicine, Endocrinology, Glucose transporter, Biochemistry and Insulin. His work in Glucose homeostasis, Glucagon, Insulin resistance, Carbohydrate metabolism and Somatostatin is related to Internal medicine. Endocrinology and Receptor are frequently intertwined in his study.
His Glucose transporter study combines topics in areas such as Molecular biology, Glucose uptake, Polyol transport and Transmembrane domain. His study in the field of Transporter, Enteroendocrine cell, Glucagon receptor family and Secretin also crosses realms of Secretin receptor family. His study focuses on the intersection of Insulin and fields such as Secretion with connections in the field of Hormone, GTP' and Cell fractionation.
Bernard Thorens mostly deals with Internal medicine, Endocrinology, Insulin, Glucose transporter and Glucose homeostasis. His work in Endocrinology addresses subjects such as Receptor, which are connected to disciplines such as Signal transduction. His Insulin research is multidisciplinary, incorporating elements of Hormone and Secretion.
His work deals with themes such as Glucose uptake, Transporter, Biochemistry, Molecular biology and Gene isoform, which intersect with Glucose transporter. His Glucose homeostasis research is multidisciplinary, incorporating perspectives in Hypothalamus, Glucokinase and Homeostasis. His Beta cell study which covers Cell biology that intersects with Gene.
Bernard Thorens mainly focuses on Internal medicine, Endocrinology, Glucose homeostasis, Insulin and Islet. His research brings together the fields of Type 2 diabetes and Internal medicine. His Endocrinology research focuses on Glucagon secretion, Glucagon, GLUT2, Beta cell and Diabetes mellitus.
Bernard Thorens has included themes like Homeostasis and Cell biology in his Glucose homeostasis study. His Insulin research incorporates themes from Cell and Carbohydrate metabolism. The Islet study combines topics in areas such as Transcriptome and Impaired glucose tolerance.
Bernard Thorens focuses on Internal medicine, Endocrinology, Insulin, Glucose homeostasis and GLUT2. His Internal medicine study often links to related topics such as Type 2 diabetes. Endocrinology is closely attributed to Receptor in his study.
His research integrates issues of Adipose tissue, Cell, Carbohydrate metabolism and Drosophila Protein in his study of Insulin. His Glucose homeostasis study frequently draws connections to other fields, such as Cell biology. His study on GLUT2 is covered under Glucose transporter.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Rongbin Zhou;Aubry Tardivel;Bernard Thorens;Inpyo Choi.
Nature Immunology (2010)
Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits.
Cecilia M. Canessa;Laurent Schild;Gary Buell;Bernard Thorens.
Nature (1994)
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.
Bernard Thorens.
Proceedings of the National Academy of Sciences of the United States of America (1992)
Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells
Thorens B;Sarkar Hk;Kaback Hr;Lodish Hf.
Cell (1988)
The SLC2 (GLUT) family of membrane transporters.
Mike Mueckler;Bernard Thorens.
Molecular Aspects of Medicine (2013)
Glucose transporters in the 21st Century
Bernard Thorens;Mike M. Mueckler.
American Journal of Physiology-endocrinology and Metabolism (2010)
The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review).
Hans-Georg Joost;Bernard Thorens.
Molecular Membrane Biology (2001)
Uric acid transport and disease.
Alexander So;Bernard Thorens.
Journal of Clinical Investigation (2010)
Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor.
Bernard Thorens;Andrée Porret;Léo Bühler;Shao-Ping Deng.
Diabetes (1993)
Glucose transporters in the 21 st Century
Bernard Thorens;Mike Mueckler.
American Journal of Physiology-endocrinology and Metabolism (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Grenoble Alpes University
Imperial College London
University of Lausanne
Université Paris Cité
MIT
University of Lausanne
University of Pisa
École Polytechnique Fédérale de Lausanne
Lunenfeld-Tanenbaum Research Institute
Imperial College London
National Institutes of Health
Nutcracker Therapeutics
Norwegian University of Science and Technology
Georgia Institute of Technology
Mount Saint Vincent University
Hefei University of Technology
Arizona State University
University of Delhi
Columbia University
University of Michigan–Ann Arbor
Inserm
Aix-Marseille University
Griffith University
University of Wisconsin–Madison
Garvan Institute of Medical Research
University of Michigan–Ann Arbor